RxDoctor Payments DataLook up a doctor →

Tiffany McConathy, APRN

Nurse Practitioner · Hot Springs, ARNPI 1164958013

Payments from drug & device makers

$53,807in general payments, 2019–2025

Across 602 payments — averaging $89.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$42K
  • Adaptive Biotechnologies Corporation$2K
  • Novartis$979
  • Pfizer$628
  • Exelixis Inc.$393
  • Bristol Myers Squibb$389
  • plus $7K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)113$42,275
Adaptive Biotechnologies Corporation3$2,096
Novartis65$979
Pfizer35$628
Exelixis Inc.21$393
Bristol Myers Squibb38$389
GSK21$384
Lilly USA, LLC18$352
Johnson & Johnson(2 entities)20$338
Amgen10$302
Merck17$295
AbbVie13$292
Takeda Pharmaceuticals U.S.A., Inc.11$292
Daiichi Sankyo Inc.10$283
Astellas Pharma US Inc8$277
Incyte Corporation11$264
Seagen Inc.16$248
Eisai Inc.13$241
Karyopharm Therapeutics Inc.7$238
Sanofi11$225
Gilead12$209
Pharmacosmos Therapeutics Inc.7$207
Bayer10$191
Array Biopharma Inc10$185
Morphosys, US Inc.10$181
Beigene USA, Inc.5$177
EMD Serono, Inc.4$173
Dendreon Pharmaceuticals LLC3$158
E.r. Squibb & Sons, L.L.C.8$150
Sumitomo Pharma America, Inc.5$118
Sirtex Medical Inc1$105
Pharmacyclics LLC, An Abbvie Company6$99
Mirati Therapeutics, Inc.5$89
Regeneron Healthcare Solutions, Inc.4$87
ADC Therapeutics America, Inc.4$79
Boehringer Ingelheim3$75
Rigel Pharmaceuticals, Inc.4$62
Spectrum Pharmaceuticals Inc.3$50
Pharmaessentia USA Corporation3$50
Sobi, Inc3$47
Epizyme, Inc.3$46
G1 Therapeutics, Inc.3$44
Stemline Therapeutics Inc.2$43
Genentech USA, Inc.3$42
Ipsen Biopharmaceuticals, Inc2$39
Puma Biotechnology, Inc.2$34
CTI Biopharma Corp.2$32
Celltrion USA Inc.1$24
Tersera Therapeutics LLC1$23
Myovant Sciences Inc.1$22
Apellis Pharmaceuticals, Inc.1$20
Heron Therapeutics, Inc.1$20
Nuvation Bio Inc.1$18
Acrotech Biopharma Inc.1$18
Blueprint Medicines Corporation1$17
Servier Pharmaceuticals LLC1$16
AVEO Pharmaceuticals, Inc.1$16
Genmab U.S., Inc.1$14
Myriad Genetic Laboratories, Inc.1$13
Shield Therapeutics Inc1$13

How this compares

$53,807 in reported general payments places this provider in the 95th percentile of 697 nurse practitioner providers in Arkansas.

See all nurse practitioner providers in Arkansas

Medicare billing

Part B allowed, 2024
$5,950
Medicare patients
56
Services billed
64

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Hot Springs

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →